US Patent Issued to INTRA-CELLULAR THERAPIES on May 26 for "Organic compounds" (New York, California, New Jersey Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,287, issued on May 26, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Organic compounds" was invented by Lawrence P. Wennogle (Hillsborough, N.J.), Joseph Hendrick (New York) and Robert Davis (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the combination of inhibitors of phosphodiesterase 1 (PDE1) useful for the treatment of certain cancers or tumors, such as gliomas. In another embodiment, the disclosure relates to the combination of inhibitors of PDE1 and an antitumor agent for the treatment of certain cancers or tumors, such as gliomas."

The patent was filed on May 24, 2019, under Applicati...